Effects of Jak2 Type 1 Inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 Mutation-Positive and Bcr-Abl-Positive Cell Lines

Publisher： Karger

E-ISSN： 1421-9662|132|1|75-86

ISSN： 0001-5792

Source： Acta Haematologica, Vol.132, Iss.1, 2014-01, pp. : 75-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2V617F Mutation Status

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-04 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

Coexistence of JAK2V617F Mutation and BCR-ABL1 Transcript in Two Chinese Patients with Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 1, 2011-10 ,pp. : 47-49

Karger

Access to resources Recommend Favorite

BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 69-70

Karger

Access to resources Recommend Favorite

JAK2V617F-Positive Essential Thrombocythemia and Multiple Myeloma with IGH/CCND1 Gene Translocation Coexist, but Originate from Separate Clones

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-01 ,pp. : 177-181

Karger

Access to resources Recommend Favorite

BCR–JAK2 drives a myeloproliferative neoplasm in transplanted mice

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 2, 2015-06 ,pp. : 219-228

John Wiley & Sons Inc

Access to resources Recommend Favorite